Diagnostic anti-[West Nile virus (WNV)] antibodies pairs for testing in ELISA, Lateral flow immunoassay (LFIA) and other immunoassays for West Nile fever.

Cat No.: GMP-WNV-1Ab

West Nile virus (WNV) is the leading cause of mosquito-borne disease in the continental United States. It is most commonly spread to people by the bite of an infected mosquito. Cases of WNV occur during mosquito season, which starts in the summer and continues through fall. There are no vaccines to prevent or medications to treat WNV in people. Fortunately, most people infected with WNV do not feel sick. About 1 in 5 people who are infected develop a fever and other symptoms. About 1 out of 150 infected people develop a serious, sometimes fatal, illness. You can reduce your risk of WNV by using insect repellent and wearing long-sleeved shirts and long pants to prevent mosquito bites.Genemedi produces core diagnostic ingredients-validated antibodies pairs Mouse anti-West Nile virus (WNV) monoclonal antibody for rapid test kit of West Nile fever (WNV) to evaluate the related human infectious disease.The paired antibodies are both monoclonal antibody(mab).

All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in diagnostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.

Order information

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-WNV-1Ab-1mg 1mg 1953
GMP-WNV-1Ab-10mg 10mg 13671
GMP-WNV-1Ab-100mg 100mg 95697
GMP-WNV-1Ab-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Antigen & Antibody Name Mouse anti-West Nile virus (WNV) monoclonal antibody
Expression platform CHO
IsotypesMouse IgG
Bioactivity validationAntibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays in[West Nile virus (WNV)] level test in human infectious disease diagnositcs-for West Nile fever.
TagmFc
Products descriptionWest Nile virus (WNV) is the leading cause of mosquito-borne disease in the continental United States. It is most commonly spread to people by the bite of an infected mosquito. Cases of WNV occur during mosquito season, which starts in the summer and continues through fall. There are no vaccines to prevent or medications to treat WNV in people. Fortunately, most people infected with WNV do not feel sick. About 1 in 5 people who are infected develop a fever and other symptoms. About 1 out of 150 infected people develop a serious, sometimes fatal, illness. You can reduce your risk of WNV by using insect repellent and wearing long-sleeved shirts and long pants to prevent mosquito bites.
PurityPurity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.